A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

Q3 2025 Earnings Call Transcript November 4, 2025 Madrigal Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

As much as we value individuality, some situations feel so clear-cut that it seems only a lunatic could have a different take ...

A research team led by Professor Wang Peng from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...

Novo Nordisk A/S delivered mixed Q3 '25 results, with modest revenue growth but 27% drop in net profit due to financing costs ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September ...

A team of scientists at the University of Seville has identified an essential process that protects DNA integrity in reproductive cells, providing new clues about how organisms avoid genetic defects ...

A research team has developed ChatLeafDisease (ChatLD) — a training-free crop disease classification framework built on the ...

Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases ...